KraneShares Emerging Market Healthcare Index ETF (KMED)

NYSEARCA: KMED · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Sep 27, 2022 12:00 AM
+0.31 (1.62%)
After-hours: Sep 28, 2022 8:00 PM EDT
Assets $1.91M
NAV $19.10
Expense Ratio 0.80%
PE Ratio 26.88
Shares Out 100,000
Dividend (ttm) $0.11
Dividend Yield 0.56%
Ex-Dividend Date Dec 29, 2021
1-Year Return n/a
Volume 2
Open 19.27
Previous Close 19.39
Day's Range 19.12 - 19.39
52-Week Low 19.12
52-Week High 31.11
Beta 0.57
Holdings 106
Inception Date Aug 29, 2018

About KMED

The fund will invest at least 80% of its net assets in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.

Asset Class Equity
Region Emerging-Broad
Issuer KraneShares
Stock Exchange NYSEARCA
Ticker Symbol KMED
Index Tracked Solactive Emerging Markets Healthcare Index

Top 10 Holdings

40.48% of assets
Name Symbol Weight
International Holdings Co PJSC n/a 7.12%
Sun Pharmaceuticals Industries Ltd SUNPHARMA.NS 4.78%
Celltrion Inc 068270.KS 4.53%
Samsung BioLogics Co Ltd 207940.KS 4.38%
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760.SZ 4.03%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276.SS 3.56%
WuXi Biologics (Cayman) Inc 2269.HK 3.13%
Aier Eye Hospital Group Co Ltd Class A 300015.SZ 3.07%
Divi's Laboratories Ltd DIVISLAB.NS 2.95%
Hapvida Participacoes Investimento SA Ordinary Shares HAPV3.SA 2.92%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 29, 2021 $0.10783 Dec 31, 2021
Dec 29, 2020 $0.0082 Dec 31, 2020
Dec 27, 2019 $0.37893 Dec 31, 2019
Dec 26, 2018 $0.00301 Dec 28, 2018
Full Dividend History


China Calls for Global Cooperation, Pledges 2 Billion Covid-19 Vaccines

The Chinese government has promised 2 billion vaccines to help developing nations in the face of the highly contagious Covid-19 variant delta, as reported by the Wall Street Journal. President XI Jinpin...

1 year ago - ETF Trends

Access the Burgeoning Healthcare Sector Overseas with ‘KMED'

Emerging markets (EM) took their lumps from the Covid-19 pandemic, but as these economies re-emerge, look to strength in the healthcare sector with the KraneShares Emerging Markets Healthcare Index ETF ...

1 year ago - ETF Trends

As WHO Approves Second Chinese Covid-19 Vaccine, ‘KMED' Could Benefit

On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters. That could b...

1 year ago - ETF Trends

3 Emerging Markets ETFs For 2021

One of the asset classes generating plenty of buzz as a 2021 idea is emerging markets. Up 4.5% over the past month, the MSCI Emerging Markets Index is already pricing in that enthusiasm.

Other symbols: FRDMXSOE
1 year ago - Benzinga